Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Orbofiban TFA is an orally active GPIIb/IIIa platelet receptor antagonist with inhibitory effects on platelet aggregation for the study of unstable coronary syndromes.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 297.00 | |
5 mg | In stock | $ 773.00 | |
10 mg | In stock | $ 1,050.00 | |
25 mg | In stock | $ 1,560.00 | |
50 mg | In stock | $ 2,090.00 | |
100 mg | In stock | $ 2,850.00 |
Description | Orbofiban TFA is an orally active GPIIb/IIIa platelet receptor antagonist with inhibitory effects on platelet aggregation for the study of unstable coronary syndromes. |
Synonyms | Orbofiban TFA(163250-90-6 Free base) |
Molecular Weight | 475.42 |
Formula | C19H24F3N5O6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Orbofiban TFA Cytoskeletal Signaling Integrin Orbofiban TFA(163250-90-6 Free base) inhibitor inhibit